News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
ROBINS CHAD M
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/08/2023 |
4
| ROBINS CHAD M (CEO and Chairman) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 354,610 shares
@ $0 |
|
| 03/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/14/2021 |
4
| ROBINS CHAD M (CEO and Chairman) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 1,501 shares
@ $38.24, valued at
$57.4k
|
|
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/06/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2021 |
4
| ROBINS CHAD M (CEO and Chairman) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 3,850 shares
@ $62.51, valued at
$240.7k
Sold 2,524 shares
@ $63.63, valued at
$160.6k
Sold 3,526 shares
@ $64.52, valued at
$227.5k
Sold 100 shares
@ $65.23, valued at
$6.5k
Sold 1,879 shares
@ $54.63, valued at
$102.6k
Sold 1,000 shares
@ $56.26, valued at
$56.3k
Sold 2,000 shares
@ $57.71, valued at
$115.4k
Sold 3,246 shares
@ $58.79, valued at
$190.8k
Sold 1,875 shares
@ $59.72, valued at
$112k
Sold 600 shares
@ $55.01, valued at
$33k
Sold 2,800 shares
@ $55.94, valued at
$156.6k
|
|
| 01/21/2021 |
4
| ROBINS CHAD M (CEO and Chairman) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 8,300 shares
@ $70.42, valued at
$584.5k
Sold 100 shares
@ $71.14, valued at
$7.1k
|
|
| 12/30/2020 |
4
| ROBINS CHAD M (CEO and Chairman) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 13,542 shares
@ $60.71, valued at
$822.1k
Sold 1,108 shares
@ $61.48, valued at
$68.1k
Sold 1,500 shares
@ $62.6, valued at
$93.9k
Sold 100 shares
@ $63.41, valued at
$6.3k
Sold 8,256 shares
@ $58.87, valued at
$486k
Sold 6,834 shares
@ $59.42, valued at
$406.1k
Sold 1,700 shares
@ $60.73, valued at
$103.2k
Sold 7,651 shares
@ $59.2, valued at
$452.9k
Sold 8,869 shares
@ $59.65, valued at
$529k
Exercised 16,250 options to buy
@ $0.33, valued at
$5.4k
Exercised 16,790 options to buy
@ $0.33, valued at
$5.5k
|
|
| 11/19/2020 |
4
| ROBINS CHAD M (CEO and Chairman) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 11,047 shares
@ $45.84, valued at
$506.4k
Sold 5,633 shares
@ $46.68, valued at
$262.9k
Sold 1,200 shares
@ $46.68, valued at
$56k
Sold 2,000 shares
@ $47.64, valued at
$95.3k
Sold 13,480 shares
@ $48.52, valued at
$654k
Sold 7,647 shares
@ $45.6, valued at
$348.7k
Sold 3,773 shares
@ $46.69, valued at
$176.2k
Sold 4,360 shares
@ $47.75, valued at
$208.2k
Sold 900 shares
@ $48.54, valued at
$43.7k
Exercised 16,680 options to buy
@ $0.33, valued at
$5.5k
Exercised 16,680 options to buy
@ $0.33, valued at
$5.5k
|
|
| 10/08/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/18/2020 |
4
| ROBINS CHAD M (CEO and Chairman) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 6,180 shares
@ $45.47, valued at
$281k
Sold 5,000 shares
@ $46.45, valued at
$232.3k
Sold 5,100 shares
@ $47.46, valued at
$242k
Sold 400 shares
@ $48.26, valued at
$19.3k
Sold 2,600 shares
@ $44.48, valued at
$115.6k
Sold 14,080 shares
@ $45.26, valued at
$637.3k
Sold 8,100 shares
@ $45.28, valued at
$366.8k
Sold 8,580 shares
@ $46.13, valued at
$395.8k
Exercised 16,680 options to buy
@ $0.33, valued at
$5.5k
Exercised 16,680 options to buy
@ $0.33, valued at
$5.5k
Exercised 16,680 options to buy
@ $0.33, valued at
$5.5k
|
|
| 08/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/31/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/19/2020 |
4
| ROBINS CHAD M (CEO and Chairman) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 400 shares
@ $43.76, valued at
$17.5k
Sold 28,040 shares
@ $44.38, valued at
$1.2M
Sold 16,680 shares
@ $44.41, valued at
$740.8k
Sold 24,160 shares
@ $44.91, valued at
$1.1M
Sold 400 shares
@ $45.52, valued at
$18.2k
Exercised 28,440 options to buy
@ $0.33, valued at
$9.4k
Exercised 16,680 options to buy
@ $0.33, valued at
$5.5k
Exercised 24,560 options to buy
@ $0.33, valued at
$8.1k
|
|
| 06/04/2020 |
3
| ROBINS CHAD M (Director) has filed a Form 3 on ARYA Sciences Acquisition Corp II |
| 05/21/2020 |
4
| ROBINS CHAD M (CEO and Chairman) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 900 shares
@ $39.31, valued at
$35.4k
Sold 49,100 shares
@ $39.95, valued at
$2M
Sold 50,000 shares
@ $40.46, valued at
$2M
Sold 50,000 shares
@ $40.29, valued at
$2M
Gifted 100,000 shares
@ $0
Exercised 50,000 options to buy
@ $0.33, valued at
$16.5k
Exercised 50,000 options to buy
@ $0.33, valued at
$16.5k
Exercised 50,000 options to buy
@ $0.33, valued at
$16.5k
|
|
| 05/08/2020 |
4
| ROBINS CHAD M (CEO and Chairman) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 36,186 shares
@ $35.47, valued at
$1.3M
Sold 8,814 shares
@ $36.13, valued at
$318.4k
Exercised 45,000 options to buy
@ $0.33, valued at
$14.9k
|
|
| 04/15/2020 |
4
| ROBINS CHAD M (CEO and Chairman) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 1,500 shares
@ $24.83, valued at
$37.2k
Sold 900 shares
@ $25.62, valued at
$23.1k
Sold 3,160 shares
@ $26.74, valued at
$84.5k
Sold 33,360 shares
@ $28.2, valued at
$940.8k
Sold 500 shares
@ $27.62, valued at
$13.8k
Sold 10,620 shares
@ $28.34, valued at
$301k
Exercised 5,560 options to buy
@ $0.33, valued at
$1.8k
Exercised 33,360 options to buy
@ $0.33, valued at
$11k
Exercised 11,120 options to buy
@ $0.33, valued at
$3.7k
|
|
| 03/23/2020 |
4
| ROBINS CHAD M (CEO and Chairman) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 11,120 shares
@ $22.3, valued at
$248k
Sold 3,700 shares
@ $22.37, valued at
$82.8k
Sold 973 shares
@ $23.5, valued at
$22.9k
Sold 887 shares
@ $24.38, valued at
$21.6k
Exercised 11,120 options to buy
@ $0.33, valued at
$3.7k
Exercised 5,560 options to buy
@ $0.33, valued at
$1.8k
|
|
| 02/18/2020 |
4
| ROBINS CHAD M (CEO and Chairman) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 11,120 shares
@ $31.56, valued at
$350.9k
Exercised 11,120 options to buy
@ $0.33, valued at
$3.7k
Granted 300,000 options to buy
@ $31.71, valued at
$9.5M
|
|
| 02/12/2020 |
4
| ROBINS CHAD M (CEO and Chairman) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 11,120 shares
@ $31.18, valued at
$346.7k
Sold 11,120 shares
@ $31.3, valued at
$348.1k
Exercised 11,120 options to buy
@ $0.33, valued at
$3.7k
Exercised 11,120 options to buy
@ $0.33, valued at
$3.7k
|
|
| 01/29/2020 |
4
| ROBINS CHAD M (CEO and Chairman) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 11,120 shares
@ $30.01, valued at
$333.7k
Sold 10,320 shares
@ $31.08, valued at
$320.7k
Sold 800 shares
@ $31.9, valued at
$25.5k
Sold 11,120 shares
@ $30.99, valued at
$344.6k
Exercised 11,120 options to buy
@ $0.33, valued at
$3.7k
Exercised 11,120 options to buy
@ $0.33, valued at
$3.7k
Exercised 11,120 options to buy
@ $0.33, valued at
$3.7k
|
|
| 10/25/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2019 |
4
| ROBINS CHAD M (CEO and Chairman) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Converted 70,680 shares
@ $0
Converted 70,680 preferred shares
@ $0 |
|
| 06/26/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|